


Cloudbreak Pharma Inc., a clinical-stage ophthalmology biotechnology company, researches and develops ophthalmic drugs for chronic eye diseases. The company develops CBT-001, which is in Phase 3 clinical trial for treating pterygium; CBT-009, a topical formulation of atropine that is in Phase 1/2 study indicated for the treatment of juvenile myopia; CBT-004, a VEGF receptor inhibitor, which is in Phase 2 clinical trial for
Opening Hour: Trading Days: 09:00-18:00
Non-trading Days: Closed
Opening Hour: Trading Days: 09:00-18:00
Non-trading Days: Closed
Opening Hour: 9am - 6pm (Mon - Sat)
Close (Sun and Public Holiday)
Opening Hour: 9am - 6pm (Mon - Sat)
10am - 6pm (Sun and Public Holiday)
Opening Hour: 9am - 6pm (Mon - Sat)
10am - 6pm (Sun and Public Holiday)
Opening Hour: 10am - 9pm (Mon - Sat)
10am - 6pm (Sun and Public Holiday)
Opening Hour: 10am - 9pm (Mon - Sat)
10am - 6pm (Sun and Public Holiday)
Opening Hour: 10am - 7pm (Mon - Sat)
10am - 6pm (Sun and Public Holiday)
Copyright © 2022 uSMART . All Rights Reserved.